BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/4/2021 1:47:10 PM | Browse: 285 | Download: 442
 |
Received |
|
2020-12-02 14:27 |
|
Peer-Review Started |
|
2020-12-02 14:29 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-12-24 19:42 |
|
Revised |
|
2020-12-29 15:14 |
|
Second Decision |
|
2021-02-22 03:35 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-03-08 06:34 |
|
Articles in Press |
|
2021-03-08 06:34 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-05-17 06:15 |
|
Typeset the Manuscript |
|
2021-06-03 00:26 |
|
Publish the Manuscript Online |
|
2021-06-04 13:47 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Minireviews |
| Article Title |
Diabetes and inflammatory diseases: An overview from the perspective of Ca2+/3'-5'-cyclic adenosine monophosphate signalling
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Leandro Bueno Bergantin |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Leandro Bueno Bergantin, PhD, Professor, Department of Pharmacology, Universidade Federal de São Paulo, Rua Pedro de Toledo, 669–Vila Clementino, São Paulo 04039-032, Brazil. leanbio39@yahoo.com.br |
| Key Words |
Diabetes, cancer, hypertension, dementia; Ca2+/3'-5'-cyclic adenosine monophosphate signalling; Ca2+ channel blockers; Pharmacotherapy; Neurodegeneration; COVID-19 |
| Core Tip |
There are several reviews in the literature about diabetes and inflammatory diseases. Nonetheless, to my knowledge, this is the first review which clearly discussed the role of Ca2+/3'-5'-cyclic adenosine monophosphate (cAMP) signalling in the link among diabetes and inflammatory diseases. This article also included a timeline of the major events in Ca2+/cAMP signalling field, and also discussed recent reports about the role of Ca2+ channel blockers for preventing Ca2+ signalling disruption due to coronavirus disease 2019 (COVID-19), including the correlation between COVID-19 and diabetes. |
| Publish Date |
2021-06-04 13:47 |
| Citation |
Bergantin LB. Diabetes and inflammatory diseases: An overview from the perspective of Ca2+/3'-5'-cyclic adenosine monophosphate signalling. World J Diabetes 2021; 12(6): 767-779 |
| URL |
https://www.wjgnet.com/1948-9358/full/v12/i6/767.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v12.i6.767 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
